Further, young women’s ER+ breast cancers have threefold increased likelihood of progressing to metastatic disease when diagnosed postpartum (PPBC) compared with nulliparous cases (Nulliparous Breast Cancer–NPBC)34. This evidence concerns the gene ESR1 and breast carcinoma.